| 000 | 01504 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516223749.0 | ||
| 264 | 0 | _c20150406 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2014.06.050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEdupuganti, Ramakrishna | |
| 245 | 0 | 0 |
_aSynthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cSep 2014 |
||
| 300 |
_a4910-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aElongation Factor 2 Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 |
_aPyrimidinones _xchemical synthesis |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aWang, Qiantao | |
| 700 | 1 | _aTavares, Clint D J | |
| 700 | 1 | _aChitjian, Catrina A | |
| 700 | 1 | _aBachman, James L | |
| 700 | 1 | _aRen, Pengyu | |
| 700 | 1 | _aAnslyn, Eric V | |
| 700 | 1 | _aDalby, Kevin N | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 22 _gno. 17 _gp. 4910-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2014.06.050 _zAvailable from publisher's website |
| 999 |
_c24029307 _d24029307 |
||